MAP4K1 inhibitors
US12202844B2 · kind B2 · utility
0Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2022 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Jul 13, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/052
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
One embodiment of the disclosure is a compound represented by Formula I or a pharmaceutically acceptable salt thereof. The variables in Formula I are defined herein. Compounds of Formula I are MAP4K1 inhibitors, which can be used to treat a diseases or disorders in a subject that benefits from control of MAP4K1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.